Related Experiment Video
Updated: Feb 17, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology
Pedro Serralheiro1,2, Andreia Soares3, Carlos M Costa Almeida4
1Norfolk and Norwich University Hospital, Colney Ln, Norwich NR47UY, UK. pedro.serralheiro@nnuh.nhs.uk.
Insights
Transforming growth factor-beta one (TGF-β1) signaling may play a role in chronic venous insufficiency. Understanding TGF-β1 pathways is crucial for managing venous diseases and improving vessel wall health.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Pathophysiology
Background:
- Chronic venous insufficiency and varicose veins represent a significant socioeconomic burden.
- Current understanding of venous pathophysiology, particularly the molecular sequence of events, remains limited.
- Transforming growth factor-beta one (TGF-β1) is a pleiotropic cytokine involved in development and disease.
Purpose of the Study:
- To elucidate the role of TGF-β1 in venous pathophysiology.
- To describe the structure, function, activation, and signaling of TGF-β1.
- To explore how TGF-β1 signaling disturbances contribute to chronic venous insufficiency.
Main Methods:
- Literature review focusing on TGF-β1.
- Analysis of TGF-β1 structure, function, and signaling pathways.
- Review of studies linking TGF-β1 to cardiovascular diseases and fibrotic processes.
Main Results:
- TGF-β1 has diverse roles in embryonic development, adult physiology, and various diseases.
- Disruptions in TGF-β1 signaling are implicated in fibrotic and cardiovascular pathologies.
- The review details the molecular mechanisms of TGF-β1 relevant to venous wall pathology.
Conclusions:
- TGF-β1 signaling pathways are critical for understanding venous pathophysiology.
- Aberrant TGF-β1 signaling may contribute to the development of chronic venous insufficiency.
- Further research into TGF-β1 is essential for improved management of venous disorders.
Abstract:
Chronic venous insufficiency and varicose veins occur commonly in affluent countries and are a socioeconomic burden. However, there remains a relative lack of knowledge about venous pathophysiology. Various theories have been suggested, yet the molecular sequence of events is poorly understood. Transforming growth factor-beta one (TGF-β1) is a highly complex polypeptide with multifunctional properties that has an active role during embryonic development, in adult organ physiology and in the pathophysiology of major diseases, including cancer and various autoimmune, fibrotic and cardiovascular diseases. Therefore, an emphasis on understanding its signaling pathways (and possible disruptions) will be an essential requirement for a better comprehension and management of specific diseases. This review aims at shedding more light on venous pathophysiology by describing the TGF-β1 structure, function, activation and signaling, and providing an overview of how this growth factor and disturbances in its signaling pathway may contribute to specific pathological processes concerning the vessel wall which, in turn, may have a role in chronic venous insufficiency.
Related Concept Videos
Venous Thrombosis I: Introduction
Varicose Veins I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...

